Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 20.59M | 20.46M | 20.79M | 20.61M | 20.90M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 20.59M | 20.46M | 20.79M | 20.61M | 20.90M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 21.07M | 23.37M | 24.27M | 25.30M | 26.35M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 10.41M | 10.67M | 8.955M | 8.429M | 10.22M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 31.48M | 34.04M | 33.23M | 33.73M | 36.57M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -10.89M | -13.59M | -12.44M | -13.12M | -15.68M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -0.475M | -0.717M | -0.799M | -0.706M | -0.609M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -11.37M | -14.30M | -13.24M | -13.82M | -16.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Income after Tax | -11.37M | -14.30M | -13.24M | -13.82M | -16.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -11.37M | -14.30M | -13.24M | -13.82M | -16.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -11.37M | -14.30M | -13.24M | -13.82M | -16.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 46.21 | 42.41 | 42.65 | 42.38 | 42.34 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 46.21 | 42.41 | 42.65 | 42.38 | 42.34 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.25 | -0.34 | -0.31 | -0.33 | -0.38 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.25 | -0.34 | -0.31 | -0.33 | -0.38 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
